Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
Compare Profit and Loss Results of Novartis India
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
1,518.00
-1,162.00
-76.55%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
1,518.00
-1,162.00
-76.55%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-32.00
35.00
109.38%
Raw Materials Consumed
199.00
475.00
-276.00
-58.11%
Power & Fuel Cost
0.00
53.00
-53.00
-100.00%
Employee Cost
18.00
368.00
-350.00
-95.11%
Operating Expenses
8.00
91.00
-83.00
-91.21%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
175.00
-165.00
-94.29%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
45.00
-36.00
-80.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
1,390.00
-1,126.00
-81.01%
Operating Profit (PBDIT) excl Other Income
91.00
128.00
-37.00
-28.91%
Other Income
41.00
18.00
23.00
127.78%
Operating Profit (PBDIT)
133.00
146.00
-13.00
-8.90%
Interest
0.00
56.00
-56.00
-100.00%
Profit before Depriciation and Tax
132.00
89.00
43.00
48.31%
Depreciation
2.00
98.00
-96.00
-97.96%
Profit Before Taxation & Exceptional Items
130.00
-8.00
138.00
1,725.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
-7.00
137.00
1,957.14%
Provision for Tax
29.00
1.00
28.00
2,800.00%
Profit After Tax
100.00
-8.00
108.00
1,350.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
781.00
-53.00
-6.79%
Profit Available for appropriations
829.00
772.00
57.00
7.38%
Appropriations
829.00
772.00
57.00
7.38%
Equity Dividend (%)
500%
10%
490.00
Earnings Per Share
40.87
-0.95
41.82
4,402.11%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024
Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024
